Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.
作者信息
Seghezzi R, Borri P, Chierichetti S, Ferrari P
出版信息
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:272-4.
PMID:4553236
Abstract
摘要
相似文献
1
Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）与羟基保泰松治疗血栓性静脉炎的对照临床试验
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:272-4.
2
Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）用于疼痛性骨关节炎病症的临床试验。
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:262-5.
3
Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).一种新型抗炎药物：4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）的临床研究
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:265-8.
4
Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）的代谢及临床效应
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:268-7.
5
Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）用于类风湿性关节炎和强直性脊柱炎的临床及实验室评估
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:253-8.
6
Clinical pharmacology of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).4-异戊二烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）的临床药理学
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:258-6.
7
[Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
Minerva Med. 1973 Oct 10;64(71):3718-24.
8
Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）在妇产科的临床及药代动力学研究
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:278-8.
9
Structure-activity relationships in anti-inflammatory compounds chemically related to 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).与4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）化学相关的抗炎化合物的构效关系。
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:174-7.
10
Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.4-异戊烯基-1,2-二苯基-3,5-吡唑烷二酮（DA 2370）在支气管肺部疾病中的临床及实验室研究
Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:274-8.
引用本文的文献
1
Treatment for superficial thrombophlebitis of the leg.腿部浅静脉血栓性静脉炎的治疗。
Cochrane Database Syst Rev. 2018 Feb 25;2(2):CD004982. doi: 10.1002/14651858.CD004982.pub6.
Zotero 插件